福元医药
(601089)
| 流通市值：76.22亿 | | | 总市值：76.22亿 |
| 流通股本：4.80亿 | | | 总股本：4.80亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 1,710,146,067.1 | 811,169,644.86 | 3,504,445,642.69 | 2,520,605,126.57 |
| 营业总成本 | 1,533,370,517.07 | 719,694,446.91 | 2,991,036,068.12 | 2,120,432,691.61 |
| 其他经营收益 | | | | |
| 营业利润 | 202,046,058.93 | 103,906,369.26 | 533,654,068.22 | 422,648,243.33 |
| 利润总额 | 200,831,661.41 | 104,056,806.28 | 523,344,365.35 | 417,863,428.34 |
| 净利润 | 187,708,519.97 | 96,197,475.14 | 471,263,535 | 377,789,952.25 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 187,708,519.97 | 96,197,475.14 | 471,263,535 | 377,789,952.25 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 2,971,535,706.38 | 3,077,741,122.89 | 3,052,506,288.44 | 2,958,350,115.16 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,837,708,383.52 | 1,857,073,193.84 | 1,871,408,865.2 | 1,834,658,419.48 |
| 资产总计 | 4,809,244,089.9 | 4,934,814,316.73 | 4,923,915,153.64 | 4,793,008,534.64 |
| 流动负债: | | | | |
| 流动负债合计 | 981,052,209.14 | 966,624,093.64 | 1,051,305,321.56 | 1,021,527,010.06 |
| 非流动负债: | | | | |
| 非流动负债合计 | 81,841,618.93 | 79,267,965.9 | 79,847,486.46 | 72,157,229.24 |
| 负债合计 | 1,062,893,828.07 | 1,045,892,059.54 | 1,131,152,808.02 | 1,093,684,239.3 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 3,731,413,375.15 | 3,874,712,009.62 | 3,779,337,701.95 | 3,685,349,376.74 |
| 股东权益合计 | 3,746,350,261.83 | 3,888,922,257.19 | 3,792,762,345.62 | 3,699,324,295.34 |
| 负债和股东权益合计 | 4,809,244,089.9 | 4,934,814,316.73 | 4,923,915,153.64 | 4,793,008,534.64 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,689,870,593.13 | 823,351,557 | 3,299,918,486.92 | 2,457,884,808.63 |
| 经营活动现金流出小计 | 1,433,036,806.78 | 717,542,984.91 | 2,939,063,950.74 | 2,143,713,079.36 |
| 经营活动产生的现金流量净额 | 256,833,786.35 | 105,808,572.09 | 360,854,536.18 | 314,171,729.27 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 4,174,339,863.22 | 2,001,314,513.06 | 8,508,507,333.68 | 7,307,197,433.33 |
| 投资活动现金流出小计 | 4,334,557,525.62 | 2,138,694,361.99 | 8,656,006,893.64 | 6,455,889,558.6 |
| 投资活动产生的现金流量净额 | -160,217,662.4 | -137,379,848.93 | -147,499,559.96 | 851,307,874.73 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 263,420.4 | - | 68,000 | - |
| 筹资活动现金流出小计 | 242,831,339.53 | 6,857,274.96 | 293,134,685.57 | 290,423,303.43 |
| 筹资活动产生的现金流量净额 | -242,567,919.13 | -6,857,274.96 | -293,066,685.57 | -290,423,303.43 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | -145,951,795.18 | -38,428,551.8 | -79,711,709.35 | 875,056,300.57 |
| 期末现金及现金等价物余额 | 488,096,299.12 | 595,619,542.5 | 634,048,094.3 | 1,588,816,104.22 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -145,951,795.18 | - | -79,711,709.35 | - |
最新报告期：2026-08-18| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 华源证券 | 刘闯,孙洁玲 | 0.79 | 0.90 | 1.04 | 2026-08-18 |